The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I also bought around these levels last year. I can find no news that explains the sharp sell off. Following ANP's half yearly results announcement on the 19th September 2013 the shares performed strongly rising from under 200p to over 300p during the 4th quarter. During the 1st half of the year to 30th June the company reported the following financial highlights: 32% increase in underlying earnings per share1 to 6.94p (2012: 5.25p) 28% rise in adjusted EBITDA2 to £1.7m (2012: £1.3m) 27% improvement in gross profit to £4.5m (2012: £3.6m) 20% uplift in sales revenue to £13.0m (2012: £10.8m) Cash balances of £5.6m at 30 June 2013 (Dec 2012: £3.7m) With the Chariman reporting as follows:- “The Group’s performance in the first half of the year has been strong with the key strategic initiatives beginning to deliver the expected benefits; some earlier than anticipated. Getting closer to our customers in target regions continues to be the priority for the Group. The second half has started well continuing the performance of the first half and we expect this growth to be maintained". Taking the weighted number of diluted shares of 19.45m and estimating a profit before tax of around £3m this would give a p/e of 17 which appears very reasonable considering the growth prospects. So unless there are some unknown surprises the trading update due over the next month should hopefully act as a positive for the share price.
It's because people are starting to get jittery about bubble stocks such as this, AGM, WAND, TLDH, UTW, ASCO and so on, i.e. companies whose valuations have run years ahead of what they are actually doing now. Shares such as these will be up and down like a *****'s knickers in the next few months as people lose faith, then try to convince themselves otherwise and back again. Saying all that, Anpario is actually a very interesting company with massive long term potential - but it's current value is probably arounf the £2 mark.
Bought them 5th November at £2.38 but still wondering why they have dropped so quickly.
Anp shares were never trading at these levels last year...must be a mistake.
Anyone have any thoughts as to the large drop over the past two days. Not seen any news and now back to where I bought these shares last year.
Relentless!!!
And still going!!
big trades after hours
left u post in BXP bb mate as for ANP - unrelenting rise, now going into USA too! China already in the bag!
is turnaround... with low EV/EBIT and prospect of improving EBIT (so TSTL imv)...ratings expansion plus profit growth equals 5-10 bagger type potential ...but you need to diversify of course and there aint enough turnarounds... ....so I like keeping my turnarounds (most obviously/prominently the 8-10 bagger rgs) for a long time as they mature (and accept high ratings/less dramatic sp growth prospects) and tri (less spectacular than rgs...but steady) and now pen (i may well get to like that one lol...good spot, shan)
so findind stocks with constant EV/EBIT preferable? TRI is good example...RGS too i think
yep
Incredible!!!
BTW - the observations in my post (its the first time I have posted) are my own. The Moneyweek cover story and share recommendation (with a 12 month price target to 350p plus potential upside) is based on ANP's role as providing substitution to antibiotics.
ANP is the star share pick of this week's Moneyweek cover story. The company continues to grow and is unigue as: 1. it has a robust BAU cash flow generating business whilst also developing innovative patented annimal additives which expand it's business lines. 2. It has no debt and pays a consistent dividend (disclosure - I have shares and have invested since 2009) 3. It is always on the look out for bolt on acquisitions (it has money in the bank) and has a history of acquiring businesses at reasonable valuations which soon after been revenue generative (the accounts evidence). 4. It benefits from a strong global trend towards increasing protein consumption (emerging markets) AND away from untargeted antibiotic usage in animal farming which could become the next consumer labelling requirement / trend. 5. It is managed by a compentent management team (I have met some of them and would prefer them to some FTSE 100 leadership teams who have made it via a politicised corporate ladder). Friday's announcement of the opening of their US office (complimenting presence in China & Brazil ) underlines the opportunity for growth and the effectiveness of management to execute their business strategy. In summary I am am long ANP and whilst their current sp is at an historical high it would be a mistake (imho) to purely value their sp on current KPIs.
...company local to me (Midlands) and focussing on solutions to improve the quality of livestock feed? Sounds like a win all-round to me. People are becoming more and more conscious of the food they eat, and as people become ever more aware of what crap is pumped into cattle normally, the demand for this kind of research and approach will grow. Might go and visit next time I'm up that way.
This was such a quiet bb until today!!!! Was on my own!!!...fab discussion guys. I guess the key is to find a company with ev/ebit that remains constant for example tri which we discussed earlier...that guarantees u growth and sp increase and hence profit!!!! Jolly looking forward to doing more analysis!!!
GDL looks really good at this Price. Look set for another rise to 24p :)
well, my wildest punt may be abm (riddler dead set against lol) ...eyeing up gdl again ...and i have a zany Bangladeshi company in my sights
You are always so jolly mate. Any tips or thinking of investing in any this week?
yup completely agree, you can also gauge where a SP in relation to the EBIT etc when there are spikes and pull backs, you can view it against the full year results. and also good when they publish the interims and you can work out how well they are doing either going up in ratios or down. :) paranoid? that doesnt sound jolly? .... ... who said that?
I always do the hard yards ..partly because i am naturally paranoid (only the paranoid survive)...but also because it forces you to really get to understand the company...it is all about the Jolly adjustments lol
I'd be surprised if the rating increased much from 15...perhaps the rating will go down as prospects of growth moderate...so expect sp trajectory to be driven by actual growth of EBIT.. to state the bleeding obvious ...this rating is similar to RGS (and I prefer RGS...a truly magnificent specimen...if I love one company, it is RGS lol)
do you use morningstar for ratios or do you prefer to work all out yourself? they give you EV/EBITDA ratios and EBIT. (you can work out EV by the EVBITDA) figures hence working out EV/EBIT but these figures are from last full years report so a lot of miss calculations and figures when SP rises and falls over the year
some companies trade on (near) infinite EV/EBIT or n/a...think of marginally profitable tech company for example ...what is BLNX's EV/EBIT? pretty high, I imagine (I still have a free carry but don't pay much attention lol)